With Merck & Co. largely propping up supplies of the bladder cancer-fighting bacteria Bacillus Calmette-Guérin (BCG) in the U.S., ImmunityBio has received the FDA all-clear to help pick up the ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback